ARCHITECT/AEROSET Activated Aspartate Aminotransferase The Activated Asparate Aminotransferase (Activated AST) assay is used for the quantitation of asparate aminotransferse in human serum or plasma
FDA Recall Z-1447-2012 · Posted 2012-04-23
Advertisement
Recalling FirmAbbott Laboratories Inc.
Recall StatusTerminated
Product CodeCIT
Date Initiated2008-06-30
Date Terminated2012-04-23
Product Quantity1,646
Reason for Recall
This letter is to inform you that some samples may generate A-AST results of less than (<) 5 U/L or results within the reference range when actual concentration exceeds the non-Flex linearity of 1985 U/L. In other cases the following errors may be generated.
-ARCHITECT cSystems: Error Code 1053 (Unable to calculate result, rate reaction linearity failure)
-AEROSET: RL% Error Code
Revised P
Firm Action
Abbott Laboratories sent a Product Correction letter dated August 5, 2008, to all affected customers. The letter identified the product, the problem, and the action to be taken by the customer. Customers were instructed to do the following:
Update your assay parameters for A-AST
1. Follow the steps in the appropriate attachment:
- Use Attachment A for ARCHITECT cSystems
- Use Attachment B for AEROSET.
2. All A-AST results of less than (<) 5 U/L should be evaluated by comparing to other clinically relevant assays
Retain a copy of this letter for your laboratory records.
For questions regarding this recall call 626-440-0705.
Root Cause
Nonconforming Material/Component
Distribution Pattern
Worldwide Distribution including Germany
Related FDA 510(k) Records
Devices referenced by this recall via K-numbers.
Official Source
View FDA Recall →Source: FDA Enforcement Report / Recall database. Always confirm against the official FDA record.
Advertisement